<SEC-DOCUMENT>0001104659-21-037119-index.html : 20210316 <SEC-HEADER>0001104659-21-037119.hdr.sgml : 20210316 <ACCEPTANCE-DATETIME>20210316161013 ACCESSION NUMBER: 0001104659-21-037119 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20210312 FILED AS OF DATE: 20210316 DATE AS OF CHANGE: 20210316 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dolan Daniel CENTRAL INDEX KEY: 0001826818 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37558 FILM NUMBER: 21745784 MAIL ADDRESS: STREET 1: C/O NABRIVA THERAPEUTICS PLC STREET 2: 1000 CONTINENTAL DRIVE, SUITE 600 CITY: KING OF PRUSSIA STATE: PA ZIP: 19406 FORMER NAME: FORMER CONFORMED NAME: Dolan Dan DATE OF NAME CHANGE: 20200930 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nabriva Therapeutics plc CENTRAL INDEX KEY: 0001641640 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 56 FITZWILLIAM SQUARE CITY: DUBLIN STATE: L2 ZIP: 2 BUSINESS PHONE: (610) 816-6640 MAIL ADDRESS: STREET 1: 1000 CONTINENTAL DRIVE STREET 2: SUITE 600 CITY: KING OF PRUSSIA STATE: PA ZIP: 19406 FORMER COMPANY: FORMER CONFORMED NAME: Nabriva Therapeutics AG DATE OF NAME CHANGE: 20150507 </SEC-HEADER> <DOCUMENT> <TYPE>3 <SEQUENCE>1 <FILENAME>tm219640-1_3seq1.xml <DESCRIPTION>OWNERSHIP DOCUMENT <TEXT> Document 1 - file: tm219640-1_3seq1.html
Document 1 - RAW XML: tm219640-1_3seq1.xml
</DOCUMENT> <DOCUMENT> <TYPE>EX-24.1 <SEQUENCE>2 <FILENAME>tm219640d1_ex24-1.htm <DESCRIPTION>EXHIBIT 24.1 <TEXT> Document 2 - file: tm219640d1_ex24-1.htm
</DOCUMENT> </SEC-DOCUMENT>